OSCR logo

Oscar Health Inc. Class A (OSCR)

$16.63

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on OSCR

Market cap

$4.40B

EPS

-1

P/E ratio

--

Price to sales

0.37

Dividend yield

--

Beta

1.877712

Price on OSCR

Previous close

$15.87

Today's open

$15.84

Day's range

$15.84 - $16.75

52 week range

$11.20 - $23.80

Profile about OSCR

CEO

Mark Bertolini

Employees

2400

Headquarters

New York, NY

Exchange

New York Stock Exchange

Shares outstanding

264684000

Issue type

Common Stock

OSCR industries and sectors

Healthcare

Medical Service Plans

News on OSCR

Is Oscar Health Stock a Buying Opportunity Before 2026?

Oscar Health's (OSCR +1.31%) management team is planning big price increases in 2026 to offset higher costs.

news source

The Motley Fool • Dec 10, 2025

news preview

Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note

The latest trading day saw Oscar Health, Inc. (OSCR) settling at $15.59, representing a -8.08% change from its previous close.

news source

Zacks Investment Research • Dec 11, 2025

news preview

Oscar Health: ACA Chaos, ICHRA Growth, And A Potential 2027 Re-Rating

Oscar Health faces ACA subsidy expiration, but aggressive repricing and ICHRA expansion support a contrarian investment thesis. Analysts project FY26 revenue of $12.6bn despite anticipated 10–20% ACA enrollment declines, driven by premium hikes offsetting volume loss and stabilizing MLR. Management's target of 2027 EPS of $2.25 and 5% operating margin implies a forward P/E of 7.6x and EV/EBIT of 4.3x. Based on these targets, OSCR could be materially undervalued.

news source

Seeking Alpha • Dec 5, 2025

news preview

Oscar Health: Banking On The ACA Enrollment Expansion (Rating Upgrade)

Oscar Health is rerated as a bullish pick, driven by ACA enrollment expansion into Alabama, Southern Florida, and other high-growth regions. OSCR projects a 2027 market reach of 24 million members without subsidies and 31 million with subsidies, supporting robust revenue growth. Despite regulatory uncertainty around ACA subsidies expiring after 2025, OSCR's expansion, affordable plans, and innovative offerings position it well for membership growth.

news source

Seeking Alpha • Dec 6, 2025

news preview

This Could Be the Most Compelling Value Play Before 2026's Economic Shift

Oscar Health is facing pressures in 2025, but these should reverse in 2026. Investors are not looking at how cheap the stock may be when it returns to profitability in 2026.

news source

The Motley Fool • Dec 1, 2025

news preview

Why This Health Care Stock Has Gained 35% This Week

Shares of Oscar Health (OSCR) jumped Wednesday, the latest big gain for the health insurer after Piper Sandler analysts upgraded their rating of the stock in a recent note to clients.

news source

Investopedia • Nov 26, 2025

news preview

Wall Street Loves Broadcom, Oscar Health, and Amazon Stocks Today

It also expects to see updated 2026 AI revenue guidance above 100% year-over-year.

news source

24/7 Wall Street • Nov 26, 2025

news preview

Health Insurers Stocks Reflect Obamacare Subsidy Deal Can Be Reached

Health insurance company stocks rose again Wednesday before the Thanksgiving holiday amid hope the Trump administration and Congress can agree on an extension of tax credits for those who buy individual coverage under the Affordable Care Act.

news source

Forbes • Nov 26, 2025

news preview

OSCR Stock Review: Strong Growth Meets Attractive Valuation

Oscar Health stock (NYSE: OSCR) has recently increased to over $16 after reports of a possible two-year extension of Obamacare subsidies, which may positively influence demand for health insurance via the Affordable Care Act (ACA) Marketplace. This surge signifies investor confidence regarding imminent policy support, yet the central question persists: Is OSCR stock still an enticing purchase following its recent increase?

news source

Forbes • Nov 25, 2025

news preview

Oscar Health's Transition Continues Following a Stake Reduction by Glynn Capital

Sold 153,753 shares of Oscar Health, a net position change of $10.47 million Transaction represented 0.8% of fund's 13F AUM Post-sale stake: 2,856,025 shares valued at $54.06 million Oscar Health remains the fund's 1st-largest holding, accounting for 17.06% of AUM

news source

The Motley Fool • Nov 24, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Oscar Health Inc. Class A

Open an M1 investment account to buy and sell Oscar Health Inc. Class A commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in OSCR on M1